Amplify Therapeutics ApS

Amplify Therapeutics ApS (CVR number: 43803999) is a company from KØBENHAVN. The company recorded a gross profit of -1558.7 kDKK in 2023. The operating profit was -2384.1 kDKK, while net earnings were -1952.7 kDKK. The profitability of the company measured by Return on Assets (ROA) was -52.4 %, which can be considered poor and Return on Equity (ROE) was -74.3 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -42.1 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Amplify Therapeutics ApS's liquidity measured by quick ratio was 5.9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.